Allogene Therapeutics, Inc. , a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.
Allogene Therapeutics stock last closed at $5.80, down 0.68% from the previous day, and has decreased 44.55% in one year. It has underperformed other stocks in the Biotechnology industry by 0.3 percentage points. Allogene Therapeutics stock is currently +31.22% from its 52-week low of $4.42, and -66.84% from its 52-week high of $17.49.
There are currently 145.84M shares of ALLO outstanding. The market cap of ALLO is $845.88M. In the last 24 hours, 1.45M ALLO shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ALLO shares.
In our opinion, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by opening an account with eToro now.Open eToro Account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to buy ALLO stock today.
Now that you have filled out your info on mobile trading apps, you can securely and quickly fund your account:
Watch this video walkthrough to see the process of depositing money into your new investment account.
Once you have chosen the best place to buy Allogene Therapeutics stock, it's very important to research their stock prior to buying, so you can wrap your head around the risk and upside.
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ALLO's stock page.
You can use many financial metrics, analyses, models, and charts to gauge ALLO's intrinsic value.
Using relative valuations metrics:
You can do additional valuation analysis on ALLO's stock here.
Out of 12 sell side analysts who monitor ALLO, the consensus analyst rating on ALLO is a Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Reni Benjamin, a top 17% analyst from JMP Securities reiterates ALLO with a buy rating and maintains their ALLO price target from $15.00 to $15.00, on Jun 5, 2023.
Tony Butler, a bottom 5% analyst from EF Hutton reiterates ALLO with a strong buy rating and maintains their ALLO price target from $15.00 to $15.00, on Jun 5, 2023.
Robert Burns, a bottom 1% analyst from HC Wainwright & Co. reiterates ALLO with a buy rating and maintains their ALLO price target from $23.00 to $23.00, on May 5, 2023.
Benjamin Burnett, a bottom 7% analyst from Stifel Nicolaus maintains ALLO with a hold rating and lowers their ALLO price target from $8.00 to $7.50, on May 4, 2023.
Luca Issi, a bottom 8% analyst from RBC Capital reiterates ALLO with a buy rating and maintains their ALLO price target from $15.00 to $15.00, on May 4, 2023.
You can dive deeper into what analysts are forecasting on the Allogene Therapeutics stock forecast page.
Last year, ALLO revenue was $234.00k. In the last 2 year, ALLO's revenue has grown by -92.19% per year. This was slower than the Biotechnology industry average of 91.4%.
Find out more about ALLO's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at ALLO have sold more shares than they have bought.
Veer Bhavnagri, General Counsel of ALLO, was the latest ALLO insider to sell. They sold $133,970.76 worth of ALLO shares on Mar 14, 2023.
Learn more about who owns ALLO stock here.
No, Allogene Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two main order types:
Click the Open button and eToro will execute the order.
If you want additional help buying stocks on eToro, click the helpful video below:
Now that you own some ALLO stock, you'll want to keep up with your stock purchase.
Make a watchlist to track the latest developments regarding your ALLO stock.
To reiterate, here are the 6 steps to buy Allogene Therapeutics stock:
If you are looking for a place to buy stocks, eToro is our recommended option.Get Started with eToro Today
If you would like to watch your investment in Allogene Therapeutics, add ALLO to your watchlist below.
How much does it cost to buy one Allogene Therapeutics share?
Is now a good time to buy Allogene Therapeutics stock?
What is the best way to buy Allogene Therapeutics stock?